Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular basis of ALS and FTD: implications for translational studies.

Arhiv za higijenu rada i toksikologiju - 1 Dec 2015

Liščić Rajka M

Abstract excerpt

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative disorders, related by signs of deteriorating motor and cognitive functions, and short survival. The cause is unknown and no effective treatment currently exists. For ALS, there is only a drug Riluzole and a promising substance arimoclomol. The overlap between ALS and FTD occurs at clinical, genetic, and pathological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis
Share to DNA-Binding Proteins
Share to Frontotemporal Dementia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to GRN gene

Share to TARDBP gene

Share to VCP gene

Share to Hydroxylamines

Share to Mutation

Source

Identifiers

PMID: 26751860
DOI: 10.1515/aiht-2015-66-2679

Genes

FUS
GRN
SOD1
TARDBP
VCP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular basis of ALS and FTD: implications for translational studies.PMID 26751860Read ↗

The molecular basis of the frontotemporal lobar degeneration–amyotrophic lateral sclerosis spectrumSemantic proximity Read ↗

Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD.Semantic proximity Read ↗

Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology.Semantic proximity Read ↗

Advances in understanding the molecular basis of frontotemporal dementia.Semantic proximity Read ↗

RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insightsSemantic proximity Read ↗

Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders.Semantic proximity Read ↗

TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.Semantic proximity Read ↗

[TDP-43 proteinopathies: ALS and frontotemporal dementias].Semantic proximity Read ↗

RNA‐binding proteins in neurodegenerative disease: TDP‐43 and beyondSemantic proximity Read ↗

From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline.Semantic proximity Read ↗

Neuronal death in amyotrophic lateral sclerosis (ALS): what can we learn from genetics?Semantic proximity Read ↗

Protein Aggregation and Defective RNA Metabolism as Mechanisms for Motor Neuron DamageSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.